American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
暂无分享,去创建一个
Diane Solomon | Anna-Barbara Moscicki | A. Moscicki | D. Solomon | D. Saslow | Robert A. Smith | C. Cohen | C. Runowicz | H. Eyre | Robert A Smith | Carolyn D Runowicz | Debbie Saslow | Harmon J Eyre | Carmel Cohen
[1] S. Mount,et al. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. , 1999, Pediatrics.
[2] W. Lawrence,et al. Benefits and costs of using HPV testing to screen for cervical cancer. , 2002, JAMA.
[3] M. Boon,et al. Diagnostic accuracy of squamous cervical lesions studied in spatula-cytobrush smears. , 1988, Acta Cytologica.
[4] D. Simel,et al. Cytologic screening after hysterectomy for benign disease. , 1995, American journal of obstetrics and gynecology.
[5] G. Kristensen,et al. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. , 1991, Acta cytologica.
[6] David R. Scott,et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. , 1994, The Journal of infectious diseases.
[7] T. Wright,et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. , 2000, Journal of the National Cancer Institute.
[8] M. Hakama,et al. Risk of cervical cancer after a negative Pap smear , 1999, Journal of medical screening.
[9] R. Ashfaq,et al. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening , 1997 .
[10] M. Fremont-Smith,et al. Direct-to-vial experience with AutoCyte PREP in a small New England regional cytology practice. , 2001, The Journal of reproductive medicine.
[11] K. Sigurdsson,et al. Trends in cervical intra‐epithelial neoplasia in Iceland through 1995, Evaluation of targeted age groups and screening intervals , 1999, Acta obstetricia et gynecologica Scandinavica.
[12] P. Remington,et al. The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result , 1999 .
[13] K. Kerlikowske,et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. , 2000 .
[14] J. Hecht,et al. Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin‐layer preparations , 2002, Cancer.
[15] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[16] Y. Qiao,et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. , 2001, Gynecologic oncology.
[17] A. Moscicki,et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. , 1998, The Journal of pediatrics.
[18] J. Cuzick,et al. HPV testing in primary screening of older women , 1999, British Journal of Cancer.
[19] C. la Vecchia,et al. Screening practices and invasive cervical cancer risk in different age strata. , 1990, Gynecologic oncology.
[20] R. Burk,et al. Natural history of cervicovaginal papillomavirus infection in young women , 1998 .
[21] Julian Peto,et al. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .
[22] S. Kabawat,et al. Performance of a fluid-based, thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. , 2009, Archives of pathology & laboratory medicine.
[23] P. Frame,et al. Determinants of Cancer Screening Frequency: The Example of Screening for Cervical Cancer , 1998, The Journal of the American Board of Family Medicine.
[24] J. Ward. Population‐based mammographic screening: Does Informed choice‘ require any less than full disclosure to individuals of benefits, harms, limitations and consequences? , 1999, Australian and New Zealand journal of public health.
[25] A. Gafni,et al. Evidence-based vs emotion-based medical decision-making: routine preoperative HIV testing vs universal precautions. , 1993, Journal of clinical epidemiology.
[26] T. Nolan,et al. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. , 1996, The New England journal of medicine.
[27] T. Wright,et al. Molecular biology of cervical cancer and its precursors , 1995, Cancer.
[28] J. Obwegeser,et al. Does Liquid-Based Technology Really Improve Detection of Cervical Neoplasia? , 2001, Acta Cytologica.
[29] D. Zahniser,et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[30] P. Sweetnam,et al. Long term follow up of women after hysterectomy with a history of pre‐invasive cancer of the cervix , 1992 .
[31] D. Fink. Change in american cancer society checkup guidelines for detection of cervical cancer , 1988, CA: a cancer journal for clinicians.
[32] J. Mandelblatt,et al. Gynecological care of elderly women. Another look at Papanicolaou smear testing. , 1986, Journal of the American Medical Association (JAMA).
[33] H. Adami,et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women , 1995, International journal of cancer.
[34] D. Provenzale,et al. Patient preferences and quality of life associated with colorectal cancer screening. , 1997, The American journal of gastroenterology.
[35] Performance of a semiautomated papanicolaou smear screening system , 1998 .
[36] H. Kitchener,et al. Efficacy of cervical-smear collection devices: a systematic review and meta-analysis , 1999, The Lancet.
[37] Daniel S. Miller,et al. Cervical Cancer Screening Among Low‐Income Women: Results of a National Screening Program, 1991–1995 , 1998, Obstetrics and gynecology.
[38] W. Hoskins,et al. Biologic course of cervical human papillomavirus infection , 1987, Obstetrics and gynecology.
[39] A. Miller,et al. Natural history of dysplasia of the uterine cervix. , 1999, Journal of the National Cancer Institute.
[40] K. Shah,et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[41] S. Sato,et al. Cervical cancer screening in Japan. A case-control study. , 1997, Acta cytologica.
[42] J. Cuzick,et al. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. , 1996, British Journal of Cancer.
[43] M. Nasiell,et al. Behavior of mild cervical dysplasia during long-term follow-up. , 1986 .
[44] C. Sung,et al. ThinPrep® pap test promotes detection of glandular lesions of the endocervix , 1999, Diagnostic cytopathology.
[45] R. Ashfaq,et al. ThinPrep Pap Test , 1999, Acta Cytologica.
[46] G. Javaheri,et al. Cervical cytology after cryosurgery, laser ablation and conization. A comparison of the cotton swab and endocervical brush. , 1993, Acta cytologica.
[47] M. Boon,et al. Analysis of five sampling methods for the preparation of cervical smears. , 1989, Acta cytologica.
[48] David R. Scott,et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. , 2003, Journal of the National Cancer Institute.
[49] M. Henry,et al. A Comparison of the Three Most Common Papanicolaou Smear Collection Techniques , 1994, Obstetrics and gynecology.
[50] T. Wright,et al. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. , 2002, JAMA.
[51] G. Vooijs,et al. False negative rate in cervical cytology. , 1987, Journal of clinical pathology.
[52] V. Václavinková. Behavior of Moderate Cervical Dysplasia During Long-Term Follow-Up , 1983, Obstetrics and gynecology.
[53] J. T. Cox,et al. ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators , 2002, Journal of lower genital tract disease.
[54] C. Clavel,et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women , 1999, British Journal of Cancer.
[55] P Sasieni,et al. Women's understanding of a “normal smear test result”: experimental questionnaire based study , 2001, BMJ : British Medical Journal.
[56] E. Franco,et al. Human papillomavirus testing for primary screening of cervical cancer precursors. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[57] V. Kataja,et al. Natural History of Cervical Human Papillomavirus Lesions Does Not Substantiate the Biologic Relevance of the Bethesda System , 1992, Obstetrics and gynecology.
[58] M. Sherman,et al. Utility of liquid‐based cytology for cervical carcinoma screening , 1999, Cancer.
[59] HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer , 2000 .
[60] I. Duncan,et al. Rationale for stopping cervical screening in women over 50. , 1993, BMJ.
[61] Mark Sherman,et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.
[62] S Wacholder,et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.
[63] D J Zahniser,et al. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor. , 1994, American journal of clinical pathology.
[64] R. Ca. The false negative smear. II. The trapping effect of collecting instruments. , 1977 .
[65] Thomas C Wright,et al. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. , 2002, Journal of lower genital tract disease.
[66] K Shy,et al. Papanicolaou smear screening interval and risk of cervical cancer , 1989, Obstetrics and gynecology.
[67] K. Kerlikowske,et al. The Positive Predictive Value of Cervical Smears in Previously Screened Postmenopausal Women: The Heart and Estrogen/progestin Replacement Study (HERS) , 2000, Annals of Internal Medicine.
[68] C. Wheeler,et al. Risk factors for rapid-onset cervical cancer. , 1999, American journal of obstetrics and gynecology.
[69] C. Clavel,et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women , 2001, British Journal of Cancer.
[70] R. Holloway,et al. The efficacy and safety of the cytobrush during pregnancy. , 1992, Gynecologic oncology.
[71] V. Wright,et al. Cyto‐histological correlates in a colposcopic clinic: A 1‐year prospective study , 1991, Diagnostic cytopathology.
[72] A. Ferenczy,et al. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. , 1999, American journal of obstetrics and gynecology.